Status:
WITHDRAWN
Novel Strategy to Encourage Early Removal of Central Venous Catheters
Lead Sponsor:
Corewell Health East
Conditions:
Vascular Access Complication
Central Line Complication
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study is to determine if early placement of a midline catheter in patients with a central venous catheter (CVC) will decrease the number of days the CVC is in place. Patients who are ...
Detailed Description
Central line-associated bloodstream infection (CLABSI) remains a serious problem contributing to patient morbidity and mortality. These potentially preventable complications have high costs. Significa...
Eligibility Criteria
Inclusion
- Adult patients 18 years of age or older admitted to the MICU at Beaumont Hospital- Royal Oak who require a CVC Midline placement by the vascular access team within 24 hours of CVC placement
Exclusion
- Patients not admitted to MICU
- Patients \< 18 years of age
- Patients identified to require a PICC for extended duration of therapy
- Patients with midline catheters, pre-existing ports, dialysis catheters (Quinton), or other vascular access already inserted within the first 24 hours of CVC insertion (peripheral IV catheters are allowed)
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04136561
Start Date
September 1 2020
End Date
December 1 2021
Last Update
September 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beaumont Hospital - Royal Oak
Royal Oak, Michigan, United States, 48073